PA-BOOMI
22.2.2024 17:18:30 CET | Business Wire | Press release
BoomiTM, the intelligent integration and automation leader, today announced that Gartner has positioned Boomi as a Leader and placed the company highest for Ability to Execute in its Magic Quadrant for Integration Platform as a Service (iPaaS). This will be the tenth consecutive time Boomi has been named a Leader in the Gartner Magic Quadrant for iPaaS. Gartner evaluated 17 iPaaS providers on their Ability to Execute and Completeness of Vision.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240221163767/en/
Boomi Celebrates Being Positioned Highest for Ability to Execute in the Gartner® Magic Quadrant™ for Integration Platform as a Service (Graphic: Business Wire)
“We believe that being positioned highest for Ability to Execute and recognized as a 10x Leader in the Gartner Magic Quadrant for iPaaS underscores our unrelenting product excellence, innovation, and execution as a team,” said Steve Lucas, CEO at Boomi. “We are pushing the envelope further than ever before to bring groundbreaking innovations to market for the benefit of our customers and partners worldwide, and it is gratifying to see the industry take note of our considerable achievements.”
Trusted by more than 20,000 customers across all industries globally for its speed, ease-of-use, and lower total cost of ownership, the cloud-native, unified, low code, scalable, open, secure, and intelligent Boomi platform helps organizations quickly and easily accelerate business outcomes.
Boomi recently announced significant updates to its platform and business, including:
Product Innovation
- Event Streams – Available through Boomi and in AWS Marketplace, the multi-tenant enterprise message queuing and streaming service allows organizations to create integrations that are more resilient, scalable, and real-time than traditional point-to-point integration processes.
- Boomi AI – Leveraging deidentified metadata, patterns, and best practices from 200 million integrations made with the Boomi platform, Boomi AI offers a simplified user experience that harnesses generative AI to connect and integrate applications, data, processes, people, and things across organizations.
- Boomi GPT – The first offering available in the Boomi AI suite, Boomi GPT brings a simple, conversational experience to the Boomi platform. With Boomi GPT, organizations can harness the power of generative AI to integrate and automate faster than ever before, further democratizing innovation and accelerating business outcomes.
- AI Patents – This year Boomi achieved two new technology patents in the field of AI that challenge the existing paradigms inherent when constructing integration processes. These patents provide additional testament to the company’s innovation leadership and dedication of its talented team of engineers, scientists, and innovators.
- New ISO Certifications – Boomi’s ISO 27001 and 27701 certifications demonstrate the company’s continued commitment to information security and privacy compliance. As one of the only iPaaS vendors that is also FedRAMP Authorized, Boomi is consistently evolving to ensure its compliance security and privacy programs continue to meet the stringent regulatory standards set by governments and its more than 20,000 worldwide customers.
- StateRAMP Authorization – Achieving StateRAMP Authorization reflects Boomi’s unwavering commitment to data security and compliance, and to delivering a secure and reliable solution that government agencies can rely on to safeguard their data and operations.
Business Growth
- Global Growth – Boomi continues to expand globally with recently opened offices in Vancouver, Barcelona, Bengaluru, and a new headquarters based in Conshohocken, PA.
- Leadership Expansion – To help usher Boomi into its next stage of growth, the company welcomed several new executive leaders throughout the past year with experience from Adobe, Business Objects, CA Technologies, Citrix, Marketo, Salesforce, and SAP.
As a category-leading, global software as a service (SaaS) company, Boomi touts a growing community of more than 100,000 members, and one of the largest arrays of global systems integrators (GSIs) in the iPaaS space. The company boasts a worldwide network of approximately 800 partners, and works with the largest hyperscaler cloud service providers.
Boomi has won numerous awards for product innovation and being an employer of choice, including being named to the 2024 list of Best Places to Work by Built In and the CRN Cloud 100 list for innovation in cloud-based technology development. In addition, Boomi has received the prestigious 5-star rating in the CRN Partner Program Guide for two consecutive years, was named a Fire Award honoree for innovation by the Philadelphia Business Journal and a Gold Stevie® Award winner in the American Business Awards for Company of the Year in 2023. Boomi has also been recognized by The Software Report as a Top 100 Software Company and for having one of the Top 50 SaaS CEOs.
To learn more, read the Gartner report: “Magic Quadrant for Integration Platform as a Service.”
Additional Resources
- Learn more about what Boomi’s placement in the Gartner Magic Quadrant for iPaaS means
- Follow Boomi on X (Twitter), LinkedIn, Facebook, and YouTube
Gartner Disclaimer:
Gartner, Magic Quadrant for Integration Platform as a Service, Keith Guttridge, Andrew Comes, Shrey Pasricha, Max van den Berk, Andrew Humphreys, February 19, 2024
Boomi was recognized as Dell Boomi in 2014-2019. The report was previously titled as Magic Quadrant for Enterprise Integration Platform as a Service from 2017-2021 and in 2014. The report was titled as Magic Quadrant for Enterprise Integration Platform as a Service, Worldwide in 2015 & 2016 and as Magic Quadrant for Integration Platform as a Service, Worldwide in 2023.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Note: Boomi was recognized as Dell Boomi from 2014 to 2019.
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240221163767/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press release
- Data on ALYFTREK in children ages 2 to 5 years demonstrate recovery of pancreatic function in some children –- Additional abstracts on clinical and real-world evidence on CFTR modulators also presented - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine p
Andersen Consulting udvider med TalentSmartEQ for at fremme lederskab og virksomhedstransformation9.10.2026 18:48:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for humankapital gennem en samarbejdsaftale med TalentSmartEQ, en San Diego-baseret virksomhed, der har fokus på at skabe praktiske, engagerende og handlingsorienterede læringsoplevelser med udgangspunkt i emotionel intelligens (EQ) og lederudvikling. I mere end to årtier har TalentSmartEQ arbejdet sammen med organisationer verden over med henblik på at udvikle ledelseskompetencer ved hjælp af emotionel intelligens og dermed styrke medarbejderengagement, teamwork og de samlede resultater. Virksomheden kombinerer forskningsbaserede metoder med praktiske læringsforløb, vurderinger, coaching og skræddersyede programmer, der skal omsætte opbygningen af emotionel intelligens til vedvarende ændringer i adfærden på arbejdspladsen. Som førende aktør i branchen samarbejder TalentSmartEQ med organisationer lige fra Fortune 500-virksomheder til offentlige myndigheder og privatejede virksomheder. "Organisationer stiller stadig større krav til dere
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press release
Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation and reinforcing the security architecture behind each financial guarantee Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Sta
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press release
We think Gartner recognizes Tecnotree's open, governed approach to agentic AI as operators make AI the engine of their revenue operations Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magi
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press release
Data Presented at Annual Meeting of European Association for Cardio-Thoracic Surgery (EACTS), Along with 6 Perceval Plus E-PostersEACTS Also Marks Commercial Launch of TriMemo and Memo 4D Curve, Innovative Repair Devices for Tricuspid and Mitral Valves Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
